Skip to content
2000
Volume 23, Issue 11
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

The arachidonic acid metabolizing enzymes, cyclooxygenase-2 (COX-2) and 5- lipoxygenase (5-LOX), are both highly expressed during the carcinogenesis in colons. Cigarette smoking promotes these carcinogenic processes at the early stage during adenoma formation. In this article, the involvement of COX-2 and 5-LOX, alongside with the dual COX/5-LOX inhibitors in colorectal cancer development is introduced. The co-regulation of 5-LOX and COX-2 in colon cancer growth and its relationship with cigarette smoke and hyaluronic acid-CD44v6 is also described. It is envisaged that dual inhibition of 5-LOX/COX could be the most promising therapeutic option for the treatment of colorectal cancer in humans.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867323666160321122431
2016-04-01
2025-07-13
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867323666160321122431
Loading

  • Article Type:
    Research Article
Keyword(s): 5-LOX; cigarette smoke; colon cancer; COX-2; hyaluronic acid; lincofelone
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test